Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 28;115(2):190–199. doi: 10.1093/jnci/djac199

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

PMC Copyright notice

Figure 2. — Million Veteran Program (MVP) cause-specific cumulative incidence. Cause-specific cumulative incidence within MVP, stratified by polygenic hazard score based on 290 common variants (PHS290), for (A) fatal prostate cancer, (B) metastatic prostate cancer, and (C) prostate cancer. PHS290 percentile groups shown for each endpoint: 0-20th, 30-70th, 80-100th, and 95-100th. Cumulative incidence for Black or African American (Black/AA) men in several PHS290 strata compared with average-risk Non-Hispanic White (PHS290 30-70th percentiles) for (D) fatal prostate cancer, (E) metastatic prostate cancer, and (F) prostate cancer. The y-axis scale was adjusted for (C) and (E) to show the higher incidence values for any prostate cancer.